Vertex Reports Fourth Quarter and Full Year 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. MRNA
9. LVS
10. MRK

Go back to Vertex Reports Fourth Quarter and Full Year 2024 Financial Results

Vertex (VRTX) PT Raised to $459 at Morgan Stanley

February 11, 2025 7:10 AM EST

Morgan Stanley analyst Terence Flynn raised the price target on Vertex (NASDAQ: VRTX) to $459.00 (from $450.00) while maintaining a Equalweight rating.

The analyst comments "VRTX posted a 4Q beat and first time 2025 Rev/expense guidance bracketed consensus. Looking ahead the focus is on... More

Vertex Pharma (VRTX) Misses Q4 EPS by 4c, Revenues Beat

February 10, 2025 4:04 PM EST

Vertex Pharma (NASDAQ: VRTX) reported Q4 EPS of $3.98, $0.04 worse than the analyst estimate of $4.02. Revenue for the quarter came in at $2.91 billion versus the consensus estimate of $2.79 billion.

GUIDANCE:

Vertex Pharma sees FY2025 revenue of $11.75-12 billion, versus the consensus of... More